User:RegainRomilly
Editor·1,611 edits·since 2025/07
RegainRomilly is an editor on PeptidePedia Wiki, editing since 2025 / 7.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
1,611Total edits
13Logged here
10Articles touched
2025/07Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Adverse effects of GLP-1 receptor agonists | 3 | 44 | 7% |
| Aspiration risk under anaesthesia | 1 | 26 | 4% |
| GenScript Peptides | 1 | 39 | 3% |
| Liquid chromatography-mass spectrometry | 1 | 28 | 4% |
| Weight regain after discontinuation | 1 | 33 | 3% |
| Bacteriostatic water | 1 | 33 | 3% |
| Solid-phase peptide synthesis | 1 | 43 | 2% |
| Haemoglobin A1c | 1 | 26 | 4% |
| Blind sampling | 1 | 33 | 3% |
| Hypoglycaemia | 1 | 26 | 4% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.